|A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses|
DC Jackson, YF Lau, T Le, A Suhrbier, G Deliyannis, C Cheers, C Smith, ...
Proceedings of the National Academy of Sciences 101 (43), 15440-15445, 2004
|Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patients|
MK Gandhi, E Lambley, J Duraiswamy, U Dua, C Smith, S Elliott, D Gill, ...
Blood 108 (7), 2280-2289, 2006
|BK polyomavirus: clinical aspects, immune regulation, and emerging therapies|
GR Ambalathingal, RS Francis, MJ Smyth, C Smith, R Khanna
Clinical microbiology reviews 30 (2), 503-528, 2017
|Effective treatment of metastatic forms of Epstein-Barr virus–associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy|
C Smith, J Tsang, L Beagley, D Chua, V Lee, V Li, DJ Moss, W Coman, ...
Cancer research 72 (5), 1116-1125, 2012
|Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma|
A Schuessler, C Smith, L Beagley, GM Boyle, S Rehan, K Matthews, ...
Cancer research 74 (13), 3466-3476, 2014
|Targeting CD39 in cancer reveals an extracellular ATP-and inflammasome-driven tumor immunity|
XY Li, AK Moesta, C Xiao, K Nakamura, M Casey, H Zhang, J Madore, ...
Cancer discovery 9 (12), 1754-1773, 2019
|Galectin-1 mediated suppression of Epstein-Barr virus–specific T-cell immunity in classic Hodgkin lymphoma|
MK Gandhi, G Moll, C Smith, U Dua, E Lambley, O Ramuz, D Gill, ...
Blood, The Journal of the American Society of Hematology 110 (4), 1326-1329, 2007
|CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses|
KE Lineburg, EJ Grant, S Swaminathan, DSM Chatzileontiadou, C Szeto, ...
Immunity 54 (5), 1055-1065. e5, 2021
|Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis|
MP Pender, PA Csurhes, C Smith, NL Douglas, MA Neller, KK Matthews, ...
JCI insight 3 (22), 2018
|Compartmentalization of total and virus-specific tissue-resident memory CD8+ T cells in human lymphoid organs|
HG Woon, A Braun, J Li, C Smith, J Edwards, F Sierro, CG Feng, ...
PLoS pathogens 12 (8), e1005799, 2016
|Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis|
MP Pender, PA Csurhes, C Smith, L Beagley, KD Hooper, M Raj, ...
Multiple Sclerosis Journal 20 (11), 1541-1544, 2014
|Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus‐specific T‐cells in patients with glioblastoma multiforme|
T Crough, L Beagley, C Smith, L Jones, DG Walker, R Khanna
Immunology and cell biology 90 (9), 872-880, 2012
|Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+ T cell recognition|
KM Tullett, IML Rojas, Y Minoda, PS Tan, JG Zhang, C Smith, R Khanna, ...
JCI insight 1 (7), 2016
|Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant recipients: a single-arm open-label phase I clinical …|
C Smith, L Beagley, S Rehan, MA Neller, P Crooks, M Solomon, ...
Clinical Infectious Diseases 68 (4), 632-640, 2019
|Cross-recognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-/nonself-recognition|
M Rist, C Smith, MJ Bell, SR Burrows, R Khanna
Blood, The Journal of the American Society of Hematology 114 (11), 2244-2253, 2009
|Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition|
J Tellam, C Smith, M Rist, N Webb, L Cooper, T Vuocolo, G Connolly, ...
Proceedings of the National Academy of Sciences 105 (27), 9319-9324, 2008
|Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno‐free CTS Immune Cell Serum Replacement|
C Smith, G Økern, S Rehan, L Beagley, SK Lee, T Aarvak, KW Schjetne, ...
Clinical & translational immunology 4 (1), e31, 2015
|Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus|
J Zhong, M Rist, L Cooper, C Smith, R Khanna
PLoS One 3 (9), e3256, 2008
|Functional reversion of antigen-specific CD8+ T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope|
C Smith, L Cooper, M Burgess, M Rist, N Webb, E Lambley, J Tellam, ...
The Journal of Immunology 177 (7), 4897-4906, 2006
|Immune regulation of human herpesviruses and its implications for human transplantation|
C Smith, R Khanna
American Journal of Transplantation 13, 9-23, 2013